Provided by Tiger Trade Technology Pte. Ltd.

TYK MEDICINES-B

2.680
-0.770-22.32%
Volume:7.77M
Turnover:22.76M
Market Cap:1.02B
PE:-2.86
High:3.550
Open:3.550
Low:2.615
Close:3.450
52wk High:22.560
52wk Low:2.615
Shares:380.07M
HK Float Shares:375.46M
Volume Ratio:0.98
T/O Rate:2.07%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.936
ROE:-70.66%
ROA:-28.19%
PB:3.34
PE(LYR):-2.86
PS:8140.32

Loading ...

TYK Medicines Schedules Board Meeting to Review Interim Results, Consider Dividend

Reuters
·
Aug 05

TYK Medicines-B Shares Surge Over 5% as Qilu Pharma Secures Exclusive Rights for Lung Cancer Drug TY-9591

Deep News
·
Jul 27

TYK Medicines files dual court actions to invalidate alleged TY-9591 agreements with Sichuan Huiyu Pharmaceutical

Bulletin Express
·
Jul 22

TYK MEDICINES-B Initiates Legal Proceedings Against Sichuan Huiyu Pharmaceutical Co., Ltd.

Stock News
·
Jul 22

Tyk Medicines - Files Legal Proceedings Against Sichuan Huiyu Pharmaceutical over Ty-9591 Agreements

THOMSON REUTERS
·
Jul 22

TYK Medicines Sues Huiyu Pharma over Disputed Ty-9591 Cooperation Deal

Reuters
·
Jul 22

Strategic Collaboration Sees Qilu Invest RMB 400 Million in TYK MEDICINES-B for TY-9591 Development and Commercialization

Stock News
·
Jul 21

TYK Medicines Prices Private Placement of 63,222,744 H Shares at HK$ 7.3 Each

Reuters
·
Jul 21

Tyk Medicines - to Receive Aggregate Upfront Payment of Rmb700 Mln Plus Potential Milestone Payments

THOMSON REUTERS
·
Jul 21

Tyk Medicines - Co Enters License and Collaboration Agreement with Qilu for Ty-9591 in China

THOMSON REUTERS
·
Jul 21

Hong Kong Shares Surge: TYK MEDICINES-B Soars Over 15% in Afternoon Trading on Key Drug Trial Results

Stock News
·
Jul 21

TYK MEDICINES-B Shares Surge Over 15% on Upcoming Commercialization of TY-9591 and Positive Clinical Data for Edotinib

Stock News
·
Jul 14

TYK MEDICINES-B Shares Surge Over 6% on Positive Clinical Data for Brain Metastasis Drug, Anticipated Q3 Launch

Stock News
·
Jul 08

TYK Medicines Convenes 15 July 2026 EGM to Secure Share-Issuance Mandate

Bulletin Express
·
Jun 29

TYK Medicines Seeks Shareholders’ Approval for 20% General Share Issuance Mandate

Bulletin Express
·
Jun 29

TYK Medicines Announces Extraordinary General Meeting

Reuters
·
Jun 29

TYK Medicines Sets 10–15 July 2026 Book Closure to Determine EGM Voting Entitlements

Bulletin Express
·
Jun 24

TYK Medicines shareholders pass Articles of Association amendments at AGM

Reuters
·
Jun 23

TYK Medicines Keeps Share Capital Steady at 380.07 Million H Shares in May; Public Float Meets 25% Rule

Bulletin Express
·
Jun 02

Major Breakthrough at ASCO 2026: TYK MEDICINES-B's Edotinib Achieves 95.5% Intracranial Objective Response Rate, Leading the Frontline Treatment for EGFR Lung Cancer Brain Metastases

Stock News
·
Jun 01